High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)-Reference-Cited by-同舟云学术

High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)

Published:2011-07 Issue:1 Volume:141 Page:119-127
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Chevaliez Stéphane,Hézode Christophe,Soulier Alexandre,Costes Bruno,Bouvier–Alias Magali,Rouanet Stéphanie,Foucher Juliette,Bronowicki Jean–Pierre,Tran Albert,Rosa Isabelle,Mathurin Philippe,Alric Laurent,Leroy Vincent,Couzigou Patrice,Mallat Ariane,Charaf–Eddine Mariem,Babany Gérard,Pawlotsky Jean–Michel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Global burden of disease (GBD) for hepatitis C;J Clin Pharmacol,2004

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

4. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies;Viruses;2021-06-09

2. Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs;Journal of Medical Virology;2018-08-16

3. IL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis C;International Journal of Biological Sciences;2016

4. Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders;Liver International;2015-04-20

5. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance;Journal of Viral Hepatitis;2015-03-26